Kendall Zaleski

Kendall Zaleski

Auto-generated profile, based on publicly available information

Kendall Zaleski

Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ANAiri Nishida
Airi Nishida
JNJun Nagai
Jun Nagai
MHMadeline Hastings
Madeline Hastings
KZKendall Zaleski
Kendall Zaleski
MSMarie Sasaki
Marie Sasaki
JBJoshua A. Boyce
Joshua A. Boyce
Platelets amplify type 2 inflammation (T2I) through incompletely understood mechanisms. Depletion of platelets markedly attenuated mast cell (MC) activation in a model of aspirin exacerbated respiratory disease (AERD) that depends on IL-33 and cysteinyl leukotrienes (cysLTs). We demonstrate an IL-33-driven feed-forward loop between platelets and MCs. IL-33 neutralization prevented increases in cysLTs and CXCL7, a platelet activation marker, in bronchoalveolar lavage (BAL) fluid from AERD-like mice in response to aspirin challenges. BAL fluid concentrations of PGD 2 correlated strongly with both CXCL7 and MC tryptase in subjects with severe asthma. Platelets amplified PGD 2 and LTC 4 productions by IL-33-stimulated mouse bone marrow–derived MCs (BMMCs), which induced release of CXCL7 and expression of CD62P by platelets. Deletions of MC-specific LTC 4 or platelet-specific type 2 cysLT receptor (CysLT 2 R) completely eliminated both platelet activation and the amplification of PGD 2 and LTC 4 generation by MCs. Platelet-derived ADP/ATP and MC-associated P2Y 1 receptors were essential. These findings identify an innate immune pathway involving MC–platelet interplay that may drive IL-33-dependent immunopathology in asthma.